✦ LIBER ✦

Cis-platin and etoposide (D-V) as second line therapy in patients with small cell lung cancer (SCLC)

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Topotecan (T) as second-line therapy fol

✍ Ruotsalainen, T; Mattson, K 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 113 KB

Etoposide (VP-16) and carboplatin as a f

📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 137 KB

216 Second-line treatment regimen in pat

✍ Orel, N.F.; Gorbunova, V.A.; Bychkov, M.B.; Smirnova, N.B. 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 149 KB

Carboplatin and etoposide (CE) in newly

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 109 KB

Cisplatin–etoposide alternating with top

✍ Mavroudis, D; Veslemes, M; Kouroussis, Ch; Tzanakis, N; Ferdoutsis, E; Toumbis, 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 97 KB

Etoposide and high dose carboplatin in p

📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 147 KB